Cargando…
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID‐19 Vaccination
OBJECTIVE: Cerebral venous thrombosis (CVT) caused by vaccine‐induced immune thrombotic thrombocytopenia (VITT) is a rare adverse effect of adenovirus‐based severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) vaccines. In March 2021, after autoimmune pathogenesis of VITT was discovered, tre...
Ejemplares similares
-
Cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia after a second ChAdOx1 nCoV-19 dose
por: Krzywicka, Katarzyna, et al.
Publicado: (2022) -
Chapter V of Regulation (EU) 2018/1725 on transfers of personal data by Union institutions and bodies to third states and international organisations
por: Tracol, Xavier
Publicado: (2021) -
Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS‐CoV‐2 vaccination
por: van de Munckhof, Anita, et al.
Publicado: (2021) -
Pollen Lipids Can Play a Role in Allergic Airway Inflammation
por: Dahl, Åslög
Publicado: (2018) -
Three years of banning neonicotinoid insecticides based on sub‐lethal effects: can we expect to see effects on bees?
por: Blacquière, Tjeerd, et al.
Publicado: (2017)